Exemestane
Summary of product characteristics
Effective Time
20220826
Version
5
Spl Product Data Elements
Exemestane Exemestane EXEMESTANE EXEMESTANE HYPROMELLOSES MAGNESIUM CARBONATE MAGNESIUM STEARATE MANNITOL CELLULOSE, MICROCRYSTALLINE POLYSORBATE 80 SODIUM STARCH GLYCOLATE TYPE A POTATO TITANIUM DIOXIDE SILICON DIOXIDE CROSPOVIDONE POLYETHYLENE GLYCOL 300 WHITE ROUND 383
Application Number
ANDA202602
Brand Name
Exemestane
Generic Name
Exemestane
Product Ndc
70771-1374
Product Type
HUMAN PRESCRIPTION DRUG
Route
ORAL
Package Label Principal Display Panel
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1374-3 in bottle of 30 tablets Exemestane Tablets, 25 mg R x only 30 tablets Exemestane Tablets, 25 mg
199 mins
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.